EPISODE · Sep 19, 2023 · 28 MIN
Developing Best-in-Class Radiopharmaceuticals for Cancer Patients
from Rx for Biotech · host Podcast Host Chris Leidli
Our guests for this podcast episode are the co-founders of Ratio Therapeutics, CEO Jack Hoppin, PhD, and Chief Scientific Officer, John Babich, PhD. Ratio Therapeutics's mission is to develop best-in-class radiopharmaceuticals for the treatment of cancers.
What this episode covers
Our guests for this podcast episode are the co-founders of Ratio Therapeutics, CEO Jack Hoppin, PhD, and Chief Scientific Officer, John Babich, PhD. Ratio Therapeutics's mission is to develop best-in-class radiopharmaceuticals for the treatment of cancers.
NOW PLAYING
Developing Best-in-Class Radiopharmaceuticals for Cancer Patients
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m